ℹ️
🇨🇿
Hledání
Hledat osoby relevantní k dotazu "drug transporter"
drug transporter
Osoba
Předměty
Osoby
Publikace
Studium
PharmDr. Zuzana Ptáčková Ph.D.
Externí osoba na Farmaceutická fakulta v Hradci Králové
16 publikací
Publikace
publication
Interactions between Maraviroc and the ABCB1, ABCG2, and ABCC2 Transporters: An Important Role in Transplacental Pharmacokinetics
2019 |
Farmaceutická fakulta v Hradci Králové
publication
MDR1 and BCRP Transporter-Mediated Drug-Drug Interaction between Rilpivirine and Abacavir and Effect on Intestinal Absorption
2017 |
Farmaceutická fakulta v Hradci Králové
publication
S-(4-Nitrobenzyl)-6-thioinosine (NBMPR) is Not a Selective Inhibitor of Equilibrative Nucleoside Transporters but Also Blocks Efflux Activity of Breast Cancer Resistance Protein
2020 |
Farmaceutická fakulta v Hradci Králové
publication
Transport of ribavirin across the rat and human placental barrier: roles of nucleoside and ATP-binding cassette drug efflux transporters
2019 |
Farmaceutická fakulta v Hradci Králové
publication
Expression of Concentrative Nucleoside Transporters (SLC28A) in the Human Placenta: Effects of Gestation Age and Prototype Differentiation-Affecting Agents
2018 |
Farmaceutická fakulta v Hradci Králové
publication
Interactions of protease inhibitors atazanavir and ritonavir with ABCB1, ABCG2, and ABCC2 transporters: Effect on transplacental disposition in rats
2018 |
Farmaceutická fakulta v Hradci Králové
publication
Equilibrative nucleoside transporter 1 (ENT1, SLC29A1) facilitates transfer of the antiretroviral drug abacavir across the placenta
2018 |
Farmaceutická fakulta v Hradci Králové
publication
Role of nucleoside transporters in transplacental pharmacokinetics of nucleoside reverse transcriptase inhibitors zidovudine and emtricitabine
2017 |
Farmaceutická fakulta v Hradci Králové
publication
Role of ABC and Solute Carrier Transporters in the Placental Transport of Lamivudine
2016 |
Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
publication
Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein (ABCB1), breast cancer resistance protein (ABCG2) and multidrug resistance-associated proteins (ABCCs)
2016 |
Farmaceutická fakulta v Hradci Králové
Načíst další publikace (6)
Loading network view...